Evogene Ltd.

Tel Aviv Stock Exchange EVGN.TA

Evogene Ltd. Share Price on January 14, 2025: USD 1.59

Evogene Ltd. Share Price is USD 1.59 on January 14, 2025, a -82.31% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
  • Evogene Ltd. 52-week high Share Price is USD 10.04 on March 05, 2024, which is 531.28% above the current Share Price.
  • Evogene Ltd. 52-week low Share Price is USD 1.24 on December 19, 2024, which is -22.16% below the current Share Price.
  • Evogene Ltd. average Share Price for the last 52 weeks is USD 4.75.
Key data
Date Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B)
Market news
Loading...
Tel Aviv Stock Exchange: EVGN.TA

Evogene Ltd.

CEO Mr. Ofer Haviv CPA
IPO Date June 13, 2007
Location Israel
Headquarters 13 Gad Feinstein Street
Employees 142
Sector Health Care
Industries
Description

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

Similar companies

BLRX.TA

BioLineRx Ltd.

USD 0.01

-11.50%

CGEN.TA

Compugen Ltd.

USD 1.85

10.75%

KMDA.TA

Kamada Ltd.

USD 7.30

-3.84%

ENLV.TA

Enlivex Therapeutics Ltd.

USD 1.16

-2.88%

StockViz Staff

January 15, 2025

Any question? Send us an email